JPH11510490A5 - - Google Patents

Info

Publication number
JPH11510490A5
JPH11510490A5 JP1997506955A JP50695597A JPH11510490A5 JP H11510490 A5 JPH11510490 A5 JP H11510490A5 JP 1997506955 A JP1997506955 A JP 1997506955A JP 50695597 A JP50695597 A JP 50695597A JP H11510490 A5 JPH11510490 A5 JP H11510490A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997506955A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11510490A (ja
Filing date
Publication date
Priority claimed from US08/506,251 external-priority patent/US6303120B1/en
Application filed filed Critical
Publication of JPH11510490A publication Critical patent/JPH11510490A/ja
Publication of JPH11510490A5 publication Critical patent/JPH11510490A5/ja
Ceased legal-status Critical Current

Links

JP9506955A 1995-07-24 1996-07-24 ルイスyエピトープの複合糖質の合成及びこれらの使用 Ceased JPH11510490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/506,251 US6303120B1 (en) 1994-03-15 1995-07-24 Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US08/506,251 1995-07-24
PCT/US1996/012115 WO1997003995A1 (en) 1995-07-24 1996-07-24 Synthesis of glycoconjugates of the lewis y epitope and uses thereof

Publications (2)

Publication Number Publication Date
JPH11510490A JPH11510490A (ja) 1999-09-14
JPH11510490A5 true JPH11510490A5 (https=) 2004-08-26

Family

ID=24013831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9506955A Ceased JPH11510490A (ja) 1995-07-24 1996-07-24 ルイスyエピトープの複合糖質の合成及びこれらの使用

Country Status (6)

Country Link
US (2) US6303120B1 (https=)
EP (1) EP0854878A4 (https=)
JP (1) JPH11510490A (https=)
AU (1) AU725715B2 (https=)
CA (1) CA2227592A1 (https=)
WO (1) WO1997003995A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303120B1 (en) 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5932553A (en) 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US7550146B2 (en) 1997-04-16 2009-06-23 Sloan-Kettering Institute For Cancer Research Glycopeptide conjugates and uses thereof
WO1998046246A1 (en) 1997-04-16 1998-10-22 Sloan-Kettering Institute For Cancer Research α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
US20030054012A1 (en) * 2000-05-12 2003-03-20 Fitzgerald David J. Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
US7314632B1 (en) * 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
DK1000163T3 (da) * 1997-07-11 2006-02-06 Us Gov Health & Human Serv Pseudomonas-exotoksin A-lignende kimære immunogener
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US7141603B2 (en) 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
JP2002507577A (ja) * 1998-03-25 2002-03-12 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ 三量体抗原性o−結合複合糖ペプチド、その製造方法及びその使用
WO2000042071A2 (en) 1999-01-12 2000-07-20 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
AU5630800A (en) 1999-06-22 2001-01-09 Arno F Spatola Antimicrobial agents
US7854934B2 (en) 1999-08-20 2010-12-21 Sloan-Kettering Institute For Cancer Research Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
US7824687B2 (en) 1999-08-20 2010-11-02 Sloan-Kettering Institute For Cancer Research Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
JP5111705B2 (ja) 1999-08-20 2013-01-09 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ 新規な複合多糖、グリコアミノ酸、これらへの中間体、及びこれらの使用
AU2001294953A1 (en) 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
US6689767B2 (en) 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
US6951847B2 (en) 2000-09-29 2005-10-04 Regents Of The University Of Minnesota Methods of treating fungal infections using lupeol
EP2230249A3 (en) 2003-02-06 2010-12-22 ChronTech Pharma AB Antigen/antibody or ligand/receptor glycosylated specificity exchangers
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
WO2007019308A2 (en) 2005-08-03 2007-02-15 The Regents Of The University Of California Illudin analogs useful as anticancer agents
WO2007051004A2 (en) * 2005-10-28 2007-05-03 The Brigham And Women's Hospital, Inc. Conjugate vaccines for non-proteinaceous antigens
WO2010002478A2 (en) * 2008-07-03 2010-01-07 University Of Georgia Research Foundation, Inc. Glycopeptide and uses thereof
WO2007079448A2 (en) * 2006-01-03 2007-07-12 University Of Georgia Research Foundation, Inc. Three component carbohydrate vaccine
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
WO2008124729A1 (en) * 2007-04-09 2008-10-16 The Regents Of The University Of California One-pot synthesis of alpha/beta-o-glycolipids
US20100324469A1 (en) * 2007-10-04 2010-12-23 Josai University Corporation Drug product, a method of administrating a vaccine using the drug product, and an apparatus for iontophoresis
WO2009132082A2 (en) * 2008-04-22 2009-10-29 Medical College Of Georgia Research Institute, Inc. Immunogenic compositions containing ceramide and methods of use thereof
WO2010006343A2 (en) * 2008-07-11 2010-01-14 Sloan-Kettering Institute For Cancer Research Glycopeptide constructs and uses thereof
US20100231101A1 (en) * 2009-02-23 2010-09-16 Richard Rubin Portable casing for housing video production equipment
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
CA2801922A1 (en) 2010-06-11 2011-12-15 Sloan-Kettering Institute For Cancer Research Multivalent glycopeptide constructs and uses thereof
MX2019012280A (es) 2017-04-11 2020-01-23 Arbutus Biopharma Corp Composiciones dirigidas.
CA3143679A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
US11524026B2 (en) 2019-12-09 2022-12-13 Wayne State University Heparanase inhibitors for treatment of diabetes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119472A1 (de) * 1991-06-13 1992-12-17 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von gal-(alpha)(1-3)/gal-(beta)(1-4)/glcnac-trisacchariden und von neuen (beta)(1-3)-verknuepften oligolactosaminen ueber neue partiell alkylierte glykale
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5622929A (en) * 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US5543505A (en) 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
AU2100595A (en) * 1994-03-15 1995-10-03 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to (h. pylori), and uses thereof
US6303120B1 (en) 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
US5708163A (en) 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof

Similar Documents

Publication Publication Date Title
JP2001526523A5 (https=)
JP2000500228A5 (https=)
JP2000500445A5 (https=)
JP2000500440A5 (https=)
JP2000500327A5 (https=)
JPH11513305A5 (https=)
JPH11512324A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000500361A5 (https=)
JP2000500446A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500226A5 (https=)
JP2000500166A5 (https=)
JP2000500407A5 (https=)
JP2000500397A5 (https=)
JPH11510490A5 (https=)
JP2000502187A5 (https=)
JPH11508354A5 (https=)
JP2000500346A5 (https=)
JP2000500257A5 (https=)